1. Home
  2. BLDR vs BLTE Comparison

BLDR vs BLTE Comparison

Compare BLDR & BLTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Builders FirstSource Inc.

BLDR

Builders FirstSource Inc.

HOLD

Current Price

$59.04

Market Cap

7.2B

ML Signal

HOLD

Logo Belite Bio Inc

BLTE

Belite Bio Inc

HOLD

Current Price

$178.23

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BLDR
BLTE
Founded
1998
2018
Country
United States
United States
Employees
N/A
N/A
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.2B
6.0B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
BLDR
BLTE
Price
$59.04
$178.23
Analyst Decision
Buy
Strong Buy
Analyst Count
18
7
Target Price
$121.76
$198.00
AVG Volume (30 Days)
1.9M
198.1K
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$15,190,638,000.00
N/A
Revenue This Year
$0.71
N/A
Revenue Next Year
$4.52
$492.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$61.19
$65.00
52 Week High
$145.68
$200.00

Technical Indicators

Market Signals
Indicator
BLDR
BLTE
Relative Strength Index (RSI) 32.26 58.07
Support Level N/A $147.34
Resistance Level $76.36 $182.61
Average True Range (ATR) 2.54 7.82
MACD -0.65 2.45
Stochastic Oscillator 1.94 57.31

Price Performance

Historical Comparison
BLDR
BLTE

About BLDR Builders FirstSource Inc.

Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.

About BLTE Belite Bio Inc

Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular degeneration (AMD), and Stargardt disease type 1 (STGD1). In addition to its product candidate (tinlarebant) which is intended for the treatment of GA and STGD1, its drug development pipeline also includes a small molecule, orally administered compound, LBS-009, which is intended for the treatment of metabolic diseases such as non-alcoholic fatty liver disease (NAFLD), nonalcoholic steatohepatitis (NASH), type 2 diabetes (T2D), and gout.

Share on Social Networks: